0 Комментарии
0 Поделились
9 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
- Статьи пользователей
- Offers
- Jobs
- Войдите, чтобы отмечать, делиться и комментировать!
- Certified Organic Sports Nutrition Supplement Manufacturer: gomzilifesciencesIn an era where athletes and fitness enthusiasts are increasingly scrutinized about what they put into their bodies, the demand for transparency has never been higher. As a premier organic sports nutrition supplement manufacturer, we specialize in bridging the gap between raw nature and peak human performance. Our mission is to empower brands to deliver high-efficacy supplements that are free...0 Комментарии 0 Поделились 290 Просмотры 0 предпросмотр
- Chlordiazepoxide Hydrochloride Market to Reach USD 245 Million by 2034According to a newly published market research report by 24LifeSciences, global Chlordiazepoxide Hydrochloride market was valued at USD 180 million in 2026 and is projected to reach USD 245 million by 2034, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 20272034. Chlordiazepoxide Hydrochloride, marketed under brand names like Librium, is a...0 Комментарии 0 Поделились 405 Просмотры 0 предпросмотр
- Global AMPK Antibody Market to Reach USD 112.8 Million by 2034According to a newly published market research report by 24LifeSciences, global AMPK antibody market was valued at USD 68.2 million in 2025 and is projected to reach USD 112.8 million by 2034, growing at a compound annual growth rate (CAGR) of 7.8% during the forecast period 20262034. AMPK (AMP-activated protein kinase) antibodies are essential unconjugated research tools that specifically...0 Комментарии 0 Поделились 243 Просмотры 0 предпросмотр
- Global Bipolar Disorder Mood Stabilizers Market to Reach USD 6.23 Billion by 2031 at 4.8% CAGRAccording to a newly published market research report by 24LifeSciences, global bipolar disorder mood stabilizers market was valued at USD 4.49 billion in 2024 and is projected to reach USD 6.23 billion by 2031, growing at a compound annual growth rate (CAGR) of 4.8% during the forecast period. Bipolar disorder mood stabilizers are a critical class of psychotropic medications designed to...0 Комментарии 0 Поделились 362 Просмотры 0 предпросмотр